Neural network helps identify many more potential targets for cancer drugs
As many as half of cancer-signaling proteins once thought to be resistant to drug treatment due to lack of targetability may, in fact, be treatable, a study conducted at Perelman School of Medicine at the University of Pennsylvania showed.The findings, published in Nature Communications, identified targetable “cryptic pockets” in these proteins using a Penn-developed neural network